Previous studies have shown that miR-543 acts in cardiac fibrosis [40], renal fibrosis [41], and endometrial fibrosis [42], and miR-1323 promotes tumor progression by targeting TP53INP1 in hepatocellular carcinoma [43]. Here, TP53INP1 is linked to renal fibrosis.